Niccolo Pantucci

Niccolo Pantucci is a Venture Partner at Beast Ventures based in London, United Kingdom. In this capacity, he specializes in executing pre-seed, seed, and early-stage technology investments across a diverse range of technical sectors, including artificial intelligence, machine learning, big data, audio technology, health technology, and SaaS platforms. Throughout his career in venture capital, Pantucci has been directly associated with at least eight disclosed venture capital transactions. His historical investment portfolio includes early participation in the 2016 seed funding round for Q Bio, alongside strategic backing for specialized technology companies such as Nutropy and Sparrho. More recently, he participated in the 2024 Series A funding round for the biotechnology enterprise Baseimmune. Pantucci's current focus remains centered on deploying capital into early-stage technology startups that are building complex, data-driven solutions for modern enterprise and healthcare markets.